Literature DB >> 21477942

Internal fiducial markers and susceptibility effects in MRI-simulation and measurement of spatial accuracy.

Joakim H Jonsson1, Anders Garpebring, Magnus G Karlsson, Tufve Nyholm.   

Abstract

BACKGROUND: It is well-known that magnetic resonance imaging (MRI) is preferable to computed tomography (CT) in radiotherapy target delineation. To benefit from this, there are two options available: transferring the MRI delineated target volume to the planning CT or performing the treatment planning directly on the MRI study. A precondition for excluding the CT study is the possibility to define internal structures visible on both the planning MRI and on the images used to position the patient at treatment. In prostate cancer radiotherapy, internal gold markers are commonly used, and they are visible on CT, MRI, x-ray, and portal images. The depiction of the markers in MRI are, however, dependent on their shape and orientation relative the main magnetic field because of susceptibility effects. In the present work, these effects are investigated and quantified using both simulations and phantom measurements. METHODS AND MATERIALS: Software that simulated the magnetic field distortions around user defined geometries of variable susceptibilities was constructed. These magnetic field perturbation maps were then reconstructed to images that were evaluated. The simulation software was validated through phantom measurements of four commercially available gold markers of different shapes and one in-house gold marker.
RESULTS: Both simulations and phantom measurements revealed small position deviations of the imaged marker positions relative the actual marker positions (<1 mm).
CONCLUSION: Cylindrical gold markers can be used as internal fiducial markers in MRI. Copyright Â
© 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21477942     DOI: 10.1016/j.ijrobp.2011.01.046

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  10 in total

1.  Registration accuracy for MR images of the prostate using a subvolume based registration protocol.

Authors:  Joakim H Jonsson; Patrik Brynolfsson; Anders Garpebring; Mikael Karlsson; Karin Söderström; Tufve Nyholm
Journal:  Radiat Oncol       Date:  2011-06-16       Impact factor: 3.481

2.  Qualitative evaluation of fiducial markers for radiotherapy imaging.

Authors:  Maria F Chan; Gil'ad N Cohen; Joseph O Deasy
Journal:  Technol Cancer Res Treat       Date:  2014-09-16

3.  Evaluation of gold fiducial marker manual localisation for magnetic resonance-only prostate radiotherapy.

Authors:  Matteo Maspero; Peter R Seevinck; Nicole J W Willems; Gonda G Sikkes; Geja J de Kogel; Hans C J de Boer; Jochem R N van der Voort van Zyp; Cornelis A T van den Berg
Journal:  Radiat Oncol       Date:  2018-06-05       Impact factor: 3.481

4.  Target definition in radiotherapy of prostate cancer using magnetic resonance imaging only workflow.

Authors:  Adalsteinn Gunnlaugsson; Emilia Persson; Christian Gustafsson; Elisabeth Kjellén; Petra Ambolt; Silke Engelholm; Per Nilsson; Lars E Olsson
Journal:  Phys Imaging Radiat Oncol       Date:  2019-03-20

5.  Assessment of dosimetric and positioning accuracy of a magnetic resonance imaging-only solution for external beam radiotherapy of pelvic anatomy.

Authors:  Reko Kemppainen; Sami Suilamo; Iiro Ranta; Marko Pesola; Aleksi Halkola; Alvin Eufemio; Heikki Minn; Jani Keyriläinen
Journal:  Phys Imaging Radiat Oncol       Date:  2019-06-22

6.  An evaluation of systematic errors on marker-based registration of computed tomography and magnetic resonance images of the liver.

Authors:  Thomas Woolcot; Evanthia Kousi; Emma Wells; Katharine Aitken; Helen Taylor; Maria A Schmidt
Journal:  Phys Imaging Radiat Oncol       Date:  2018-09-06

7.  Radiotherapy planning using MRI.

Authors:  Maria A Schmidt; Geoffrey S Payne
Journal:  Phys Med Biol       Date:  2015-10-28       Impact factor: 3.609

8.  Variability in prostate and seminal vesicle delineations defined on magnetic resonance images, a multi-observer, -center and -sequence study.

Authors:  Tufve Nyholm; Joakim Jonsson; Karin Söderström; Per Bergström; Andreas Carlberg; Gunilla Frykholm; Claus F Behrens; Poul Flemming Geertsen; Redas Trepiakas; Scott Hanvey; Azmat Sadozye; Jawaher Ansari; Hazel McCallum; John Frew; Rhona McMenemin; Björn Zackrisson
Journal:  Radiat Oncol       Date:  2013-05-24       Impact factor: 3.481

Review 9.  Medical physics challenges in clinical MR-guided radiotherapy.

Authors:  Christopher Kurz; Giulia Buizza; Guillaume Landry; Florian Kamp; Moritz Rabe; Chiara Paganelli; Guido Baroni; Michael Reiner; Paul J Keall; Cornelis A T van den Berg; Marco Riboldi
Journal:  Radiat Oncol       Date:  2020-05-05       Impact factor: 3.481

10.  Using C-Arm X-ray images from marker insertion to confirm the gold fiducial marker identification in an MRI-only prostate radiotherapy workflow.

Authors:  Christian Gustafsson; Emilia Persson; Adalsteinn Gunnlaugsson; Lars E Olsson
Journal:  J Appl Clin Med Phys       Date:  2018-10-24       Impact factor: 2.102

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.